Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation.
about
PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgammaAdipogenesisSumoylation in gene regulation, human disease, and therapeutic action.The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumoniaAutophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPARγ2 degradationProteomic analysis of primary cultures of human adipose-derived stem cells: modulation by Adipogenesis.Emerging roles of SUMO modification in arthritis.Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cellsLigand binding reduces SUMOylation of the peroxisome proliferator-activated receptor γ (PPARγ) activation function 1 (AF1) domainThe story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγPeroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrolRetinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesPPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal.Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator.Transcriptional factors that promote formation of white adipose tissue.Control of nuclear receptor activities in metabolism by post-translational modifications.The multifaceted factor peroxisome proliferator-activated receptor γ (PPARγ) in metabolism, immunity, and cancer.Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.PPARγ signaling and emerging opportunities for improved therapeutics.Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.Caspase-mediated degradation of PPARgamma proteins in adipocytes.PPARγ: no SirT, no service.Functional Regulation of PPARs through Post-Translational Modifications.
P2860
Q24633440-164C8618-769A-462A-B211-F01F6E211A5DQ24685818-990402F1-D54C-4ED2-9714-B97461335F4DQ26828614-F12DD199-8A66-41B4-B076-B837F44CDC82Q27865271-4FDD9096-D880-4803-936B-12E6E06921B3Q28917164-B5C14789-CBFD-48F6-9F85-38A901F20288Q30456765-7B818516-6ABE-4C9B-8327-C4FE56767282Q31151929-7DFF6ADD-AD14-4F86-A36D-616BD24E87E7Q34108064-DEB2185B-68A3-4FFD-9BA6-DCC79A46A62FQ34315432-15C733EA-ECA7-438B-8448-E72F2C60C30CQ34365660-27D8A56E-FAC8-4A0C-AE82-8A2D0CFF7F01Q34796273-43F67C5B-7019-4C6E-9D4A-1D2A0B0A4668Q35964903-B3F2A89B-8680-47F2-9CAF-F05B53848D97Q35969865-324CA11D-701D-429D-B852-92E8B6196021Q36187022-1954CE58-65FE-4400-A8A4-516AC04B2D4AQ36980325-9FDC64A4-C890-45A7-881F-8D97A5186009Q37129586-A747429F-7634-4CF7-8476-95AB60BE6E54Q37182794-0D7710EB-8A6D-45F2-B925-B0EA9DD9300DQ37360041-7B9D7125-2DC3-4F2F-870E-942BE6E7F2BDQ37377433-934C7A25-4532-49F8-B414-24144244DE22Q37592660-F5C53E26-E6B1-4394-899B-5F243CF24E66Q37864394-59C4B022-7588-4B2C-B663-E5EC062082D0Q38314756-4C2BAC69-F931-4801-A452-D436BC77773CQ38820125-F791C0E2-7071-4967-AA98-10551439C17CQ38856983-8CB200AD-1D72-4461-B880-B4649E106188Q40576825-78A8C0A4-4765-4D2E-B05D-EF1176972A44Q40895648-4350C029-AE26-4A0A-8626-2E116E384D9BQ42812731-010620EB-2B09-4CF2-BFB5-BD3E1D34289AQ43240954-3976D647-4AD9-49F1-9452-0C17EDA82C3DQ55644874-EC3F5322-02F2-4C88-B918-BCEBB1B9B17C
P2860
Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Control of peroxisome prolifer ...... y and activity by SUMOylation.
@en
type
label
Control of peroxisome prolifer ...... y and activity by SUMOylation.
@en
prefLabel
Control of peroxisome prolifer ...... y and activity by SUMOylation.
@en
P2860
P356
P1433
P1476
Control of peroxisome prolifer ...... ty and activity by SUMOylation
@en
P2093
Z Elizabeth Floyd
P2860
P304
P356
10.1038/OBY.2004.112
P577
2004-06-01T00:00:00Z